Opendata, web and dolomites

ImMoRiSt

Immune Monitoring for RIsk STratification in Solid Organ Transplant Recipients

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 ImMoRiSt project word cloud

Explore the words cloud of the ImMoRiSt project. It provides you a very rough idea of what is the project "ImMoRiSt" about.

selectively    germany    transplant    leader    switzerland    logical    solid    right    complications    parallel    detection    centers    obtaining    regulatory    stimulate    monitoring    blood    release    heart    scan    frequency    organ    kidney    setting    stimulants    ivd    infections    entry    transplantation    performed    functional    dosage    biosciences    liver    proprietary    competitor    ifn    outcome    rejection    biomarker    drugs    validation    links    immune    place    patient    cell    firm    uses    function    feasibility    business    improves    caused    explore    final    strength    highest    clinical    marking    yield    cells    recipients    diagnostic    immunomonitoring    plan    obtain    quantitative    physicians    patients    gamma    mediated    relatively    immunosuppressive    approval    24    triggered    market    freedom    sot    interferon    lung    every    suited    lophius    cocktail    clinically    ce    qualitative    grow    austria    provides    validate    strategy    pursued    operate    tests    transplanted    global   

Project "ImMoRiSt" data sheet

The following table provides information about the project.

Coordinator
LOPHIUS BIOSCIENCES GMBH 

Organization address
address: AM BIOPARK 13
city: REGENSBURG
postcode: 93053
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Germany [DE]
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.1.3. (Treating and managing disease)
 Code Call H2020-SMEINST-1-2015
 Funding Scheme SME-1
 Starting year 2016
 Duration (year-month-day) from 2016-02-01   to  2016-07-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    LOPHIUS BIOSCIENCES GMBH DE (REGENSBURG) coordinator 50˙000.00

Map

 Project objective

Every year ~ 40.000 patients throughout the EU are transplanted a new kidney, lung, liver, heart or another organ. The frequency of clinical complications is relatively high because at present there are no diagnostic tests that help physicians to determine the right dosage of immunosuppressive drugs necessary to avoid both organ rejection and clinical complications caused by infections.

Lophius Biosciences GmbH has developed I-Scan, a functional immune monitoring test that within 24 h provides important information on the strength of the immune system in solid organ transplant recipients. I-Scan uses a proprietary cocktail of stimulants that selectively stimulate the clinically relevant immune cells in a patient’s blood sample. The detection of the triggered interferon γ (IFN-γ) release provides a qualitative and quantitative measurement of cell-mediated immune function.

The feasibility study performed during Phase 1 will explore issues related to both, the clinical biomarker validation study and the best market entry strategy. Several objectives are pursued in parallel and encompass: • Setting up the business plan which includes a competitor as well as a freedom-to-operate analysis and a market entry strategy. • Selection of clinical study partners and defining the design of the clinical study, best suited to yield highest clinical evidence • Obtaining regulatory approval for the planned clinical study and setting a strategy to obtain regulatory approval / CE-Marking for final I-Scan products.

Lophius will apply for Phase 2 funding of a clinical study to validate that I-Scan improves the outcome of SOT patients. This study is likely to take place in Germany, Switzerland and Austria where Lophius has already established firm links to transplantation centers. The study is the logical next step to further grow Lophius to become a global leader in the IVD market for immunomonitoring

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "IMMORIST" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "IMMORIST" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.3.)

CLOSER (2019)

Childhood Leukemia: Overcoming distance between South America and Europe Regions

Read More  

GACD (2019)

Global Alliance for Chronic Diseases Secretariat

Read More  

ESCALON (2019)

European-Latin American network for the assessment of biomarkers to predict and diagnose hepatobiliary malignancies and characterization of risk factors for cancer development

Read More